Literature DB >> 17473834

Estimating cancer risk in HNPCC by the GRL method.

Flora Alarcon1, Christine Lasset, Jérôme Carayol, Valérie Bonadona, Hervé Perdry, Françoise Desseigne, Qing Wang, Catherine Bonaïti-Pellié.   

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant syndrome caused by germline mutations of the mismatch repair (MMR) genes. Only a few studies have taken into account the selection of families tested for these mutations in estimating colorectal cancer (CRC) risk in carriers. They found much lower estimates of CRC risks than previous ones, but these estimates lacked precision despite the large number of families. The aim of this study was to evaluate the efficiency of the 'genotype restricted likelihood' (GRL) method that provides unbiased estimates of risks whatever the ascertainment process of families, and to estimate CRC and endometrial cancer risk for carriers of the MMR genes. Efficiency of the GRL method was evaluated using simulations. Risks were estimated from a sample of 36 families diagnosed with HNPCC and carrying a mutation of MSH2 or MLH1, ascertained through a cancer family clinic in Lyon (France). The efficiency of the GRL method was found to be strongly dependent on the proportion of family members tested. By age 70 years, CRC risk was estimated at 47% (95% confidence interval: 12-98%) for men and 33% (95% confidence interval: 24-54%) for women. The endometrial cancer risk was only 14% (confidence interval: 6-20%). As methods allowing for the selection of families lack efficiency, large-scale family studies should be undertaken and data should be pooled to provide reliable and precise estimates of risks for an optimal familial management.

Entities:  

Mesh:

Year:  2007        PMID: 17473834     DOI: 10.1038/sj.ejhg.5201843

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  16 in total

1.  Estimating penetrance from multiple case families with predisposing mutations: extension of the 'genotype-restricted likelihood' (GRL) method.

Authors:  Bernard Bonaïti; Valérie Bonadona; Hervé Perdry; Nadine Andrieu; Catherine Bonaïti-Pellié
Journal:  Eur J Hum Genet       Date:  2010-10-06       Impact factor: 4.246

2.  PEL: an unbiased method for estimating age-dependent genetic disease risk from pedigree data unselected for family history.

Authors:  F Alarcon; C Bourgain; M Gauthier-Villars; V Planté-Bordeneuve; D Stoppa-Lyonnet; C Bonaïti-Pellié
Journal:  Genet Epidemiol       Date:  2009-07       Impact factor: 2.135

Review 3.  ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes.

Authors:  Sapna Syngal; Randall E Brand; James M Church; Francis M Giardiello; Heather L Hampel; Randall W Burt
Journal:  Am J Gastroenterol       Date:  2015-02-03       Impact factor: 10.864

4.  Evaluation of Lynch syndrome modifier genes in 748 MMR mutation carriers.

Authors:  Solene Houlle; Françoise Charbonnier; Estelle Houivet; Julie Tinat; Marie-Pierre Buisine; Olivier Caron; Jacques Benichou; Stéphanie Baert-Desurmont; Thierry Frebourg
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246

5.  MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer.

Authors:  Bente A Talseth-Palmer; Mary McPhillips; Claire Groombridge; Allan Spigelman; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2010-05-21       Impact factor: 2.857

6.  Colorectal cancer surveillance in Portuguese families with lynch syndrome: a cohort study.

Authors:  Rita Vale Rodrigues; Isabel Claro; Pedro Lage; Isadora Rosa; Sara Ferreira; João Pereira da Silva; António Dias Pereira
Journal:  Int J Colorectal Dis       Date:  2018-03-09       Impact factor: 2.571

7.  High risk of colorectal and endometrial cancer in Ashkenazi families with the MSH2 A636P founder mutation.

Authors:  Bhramar Mukherjee; Gad Rennert; Jaeil Ahn; Sara Dishon; Flavio Lejbkowicz; Hedy S Rennert; Stacey Shiovitz; Victor Moreno; Stephen B Gruber
Journal:  Gastroenterology       Date:  2011-03-16       Impact factor: 22.682

8.  Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome.

Authors:  Elena Stoffel; Bhramar Mukherjee; Victoria M Raymond; Nabihah Tayob; Fay Kastrinos; Jennifer Sparr; Fei Wang; Prathap Bandipalliam; Sapna Syngal; Stephen B Gruber
Journal:  Gastroenterology       Date:  2009-07-18       Impact factor: 22.682

Review 9.  Cancer risk in Lynch Syndrome.

Authors:  Emma Barrow; James Hill; D Gareth Evans
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

10.  Penetrance of HNPCC-related cancers in a retrolective cohort of 12 large Newfoundland families carrying a MSH2 founder mutation: an evaluation using modified segregation models.

Authors:  Karen A Kopciuk; Yun-Hee Choi; Elena Parkhomenko; Patrick Parfrey; John McLaughlin; Jane Green; Laurent Briollais
Journal:  Hered Cancer Clin Pract       Date:  2009-10-28       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.